References
- Abdullah R, Zafar W, Nadeem M, Iqtedar M, Naz S, Syed Q, Kaleem A. 2015. Process optimisation for the biosynthesis of cellulase by Bacillus PC-BC6 and its mutant derivative Bacillus N3 using submerged fermentation. Nat Prod Res. 29:1133–1138.10.1080/14786419.2014.981186
- Chakraborty K, Thilakan B, Raola VK. 2014. Polyketide Family of Novel Antibacterial 7-O-Methyl-5′-hydroxy-3′-heptenoate-Macrolactin from Seaweed-Associated Bacillus subtilis MTCC 10403. J Agr Food Chem. 62:12194–12208.10.1021/jf504845m
- Elkahoui S, Abdel rahim Hamdi, Tabbene O, Shaaban M, Limam F, Laatsch H. 2013. Cyclo-(His, Leu): A new microbial diketopiperazine from a terrestrial Bacillus subtilis strain B38. Nat Prod Res. 27:108–116.10.1080/14786419.2012.660635
- Gustafson K, Roman M, Fenical W. 1989. The macrolactins, a novel class of antiviral and cytotoxic macrolides from a deep-sea marine bacterium. J Am Chem Soc. 111:7519–7524.10.1021/ja00201a036
- Jaruchoktaweechai C, Suwanborirux K, Tanasupawatt S, Kittakoop P, Menasveta P. 2000. New macrolactins from a marine Bacillus sp. Sc026. J Nat Prod. 63:984–986.10.1021/np990605c
- Kang Y, Regmi SC, Kim MY, Banskota S, Gautam J, Kim DH, Kim JA. 2015. Anti-angiogenic activity of macrolactin A and its succinyl derivative is mediated through inhibition of class I PI3K activity and its signaling. Arch Pharmacal Res. 38:249–260.10.1007/s12272-014-0535-x
- Lee SJ, Cho JY, Cho JI, Moon JH, Park KD, Lee YJ, Park KH. 2004. Isolation and characterization of antimicrobial substance macrolactin a produced from Bacillus amyloliquefaciens CHO104 isolated from soil. J Microbiol Biotechn. 14:525–531.
- Lu XL, Xu QZ, Shen YH, Liu XY, Jiao BH, Zhang WD, Ni KY. 2008. Macrolactin S, a novel macrolactin antibiotic from marine Bacillus sp. Nat Prod Res. 22:342–347.10.1080/14786410701768162
- Park S, Regmi SC, Park SY, Lee EK, Chang JH, Ku SK, Kim DH, Kim JA. 2014. Protective effect of 7-O-succinyl macrolactin A against intestinal inflammation is mediated through PI3-kinase/Akt/mTOR and NF-κB signaling pathways. Eur J Pharmacol. 735:184–192.10.1016/j.ejphar.2014.04.024
- Romero-Tabarez M, Jansen R, Sylla M, Lunsdorf H, Haussler S, Santosa DA, Timmis KN, Molinari G. 2006. 7-O-malonyl macrolactin A, a new macrolactin antibiotic from bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and a small-colony variant of Burkholderia cepacia. Antimicrob Agents Ch. 50:1701–1709.10.1128/AAC.50.5.1701-1709.2006
- Wang, T., Wu, M.-B., Chen, Z.-J., Lin, J.-P., Yang, L.-R., 2015. Separation, determination and antifungal activity test of the products from a new Bacillus amyloliquefaciens. Nat Prod Res. 3:1–4.
- Woo JH, Kitamura E, Myouga H, Kamei Y. 2002. An antifungal protein from the marine bacterium Streptomyces sp. strain AP77 is specific for Pythium porphyrae, a causative agent of red rot disease in Porphyra spp. Appl Environ Microb. 68:2666–2675.10.1128/AEM.68.6.2666-2675.2002
- Zhuang P, Tang XX, Yi ZW, Qiu YK, Wu Z. 2012. Two new compounds from marine-derived fungus Penicillium sp F11. J Asian Nat Prod Res. 14:197–203.10.1080/10286020.2011.634279